scarletred
Home
Company
Products
Scarletred
®Vision
Scarletred
®Telemedicine
Services
Applications
News
Contact
Menu
01
Home
02
Company
03
Products
04
Services
05
Applications
06
News
07
Contact
Get in touch
Austria
SCARLETRED Holding GmbH
MQM 3.4, Maria Jacobi Gasse 1,
8th floor, 1030 Vienna, Austria
USA
SCARLETRED Inc.
1 Broadway, 14th floor,
Cambridge, MA 02142, USA
office@scarletred.com
Privacy Policy
Social
Linkedin
Linkedin
Linkedin
Twitter
Instagram
Instagram
Facebook
Facebook
info
Press
Career
FAQ
Regulatory
Imprint
Clinical Trial
Keywords:
#
GlobalFemaleLeaders
#
GFL
#
EWMD
#
Arab Health 2022
#
Discovery Program
#
IÖB
#
Inflammatory Skin Disease Summit
News
•
Mar 21, 2022
Benefits of Using Scarletred®Vision for Phase IV Post-Marketing Studies
Post-Marketing Studies play an integral role in gathering information about safety and efficacy on a large scale. However, monitoring adverse events and patient-reported outcomes in a real-world setting can be challenging.
News
•
Mar 1, 2022
Meet SCARLETRED at the 3rd Dermatology Drug Development Europe Summit
Following a successful launch in Europe in 2019, and a tremendous online experience in 2021, the 3rd Dermatology Drug Development Europe Summit, returns in April 2022 in Frankfurt, Germany.
Article
•
Feb 21, 2022
How Artificial Intelligence and Telemedicine are Transforming Hybrid and Home-Based Trials
Digitalization and telemedicine have shown significant advancements in the medical industry. Still, clinical research will continue to need high-quality tools to conduct trials efficiently and decrease strain on patients.
Publication
•
September 27, 2021
The mathematics of erythema: Development of machine learning models for artificial intelligence assisted measurement and severity scoring of radiation induced dermatitis
Read more